Megan McArdle, a conservative blogger at The Atlantic Monthly notes an analysis:
Kevin Kinsella, the founder of VC firm Avalon Ventures, says that big pharmaceutical firms are essentially eating their seed corn–letting greed drive them into cutting deals that fundamentally undermine the health of the biotech industry that provides a lot of their innovation
At a time when the best way to get a job is to already have one…
Please share widely!
Our current market system has a lot of irrationalities when it comes to drug development. As your second link notes, the difficulty in profiting from drugs treating chronic diseases prevents the innovation a competitive system is supposed to give us. There’s a similar problem with drugs treating diseases that only afflict smaller populations.